CD47 is a regulator in doxorubicin-induced cardiac aging in male mice. [PDF]
Yan A +5 more
europepmc +1 more source
Tackling anti-tumor macrophage function through genome engineering. [PDF]
Kaushal R, Skeate JG, Crane AT.
europepmc +1 more source
CD47 monoclonal antibody enhances the inhibitory effect of anti-HER2 chimeric antigen receptor macrophages on ovarian cancer. [PDF]
Qiao J, Kou Q, Qiu J.
europepmc +1 more source
Targeting the CD47-SIRPα Axis in Atherosclerosis: From Pathogenesis to Therapeutic Implications. [PDF]
Sun C +5 more
europepmc +1 more source
CD200-CD200R as a myeloid immune checkpoint in solid tumors: mechanisms, context-dependent functions, and therapeutic opportunities. [PDF]
Sahu MR +5 more
europepmc +1 more source
Hypoimmune platforms: from rejection to immune evasion and regulatory implications. [PDF]
Campo F +4 more
europepmc +1 more source
Foretinib triggers immunogenic cell death and enhances efficacy of anti-CD47 immunotherapy in colorectal cancer. [PDF]
Li L +10 more
europepmc +1 more source
Local Nanomedicine and Nano-Enabled Biomaterials After Glioblastoma Resection. [PDF]
Ming Q +6 more
europepmc +1 more source
Hypoxia-Induced Expression of miR-424, miR-155, CD47, and PD-L1 in a Gastric Cancer Cell Line (MKN-45). [PDF]
Samemaleki S +3 more
europepmc +1 more source
NF-κB-driven immune checkpoint knockdown and cytokine expression in cancer cells for tumor immunotherapy. [PDF]
Wang Y +10 more
europepmc +1 more source

